Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Centers for Medicare & Medicaid Services (CMS)

HHS: Nearly 12 Million People with Medicare Have Saved $26 Billion on Prescription Drugs Since 2010

Medicare 1Washington, DC, January 16, 2017 — The Department of Health and Human Services on January 13 released new information that shows that millions of seniors and people with disabilities with Medicare continue to save on prescription drugs and see improved benefits in 2016 as a result of the Affordable Care Act.

More than 11.8 million Medicare beneficiaries have received discounts over $26.8 billion on prescription drugs — an average of $2,272 per beneficiary — since the enactment of the Affordable Care Act.

In 2016 alone, over 4.9 million seniors and people with disabilities received discounts of over $5.6 billion, for an average of $1,149 per beneficiary. Continue reading

CMS Releases Prescription Drug Cost Data; Annual Data Release Provides Clearer Look into Medicare Part D Costs

Medicare Part D 1Washington, DC, August 18, 2016 — Continuing the commitment to greater data transparency, the Centers for Medicare & Medicare Services (CMS) today released privacy-protected data on the prescription drugs that were paid for under the Medicare Part D Prescription Drug Program in 2014.

This is the second release of the data on an annual basis, which shows which prescription drugs were prescribed to Medicare Part D enrollees by physicians and other healthcare professionals.

“With this data release, patients, researchers and providers can access valuable information about the Medicare prescription drug program,” said Niall Brennan, CMS Chief Data Officer.  “Today’s release joins a series of actions the Administration is taking to improve transparency around government data, including the cost of prescription drugs.” Continue reading

CMS Proposes to Test New Medicare Part B Prescription Drug Models to Improve Quality of Care, Deliver Value

Clinical Trial 1Washington, DC, March 9, 2016 ― The Centers for Medicare & Medicaid Services (CMS) yesterday announced a proposed rule to test new models to improve how Medicare Part B pays for prescription drugs and supports physicians and other clinicians in delivering higher quality care.

CMS values public input and comments as part of the rulemaking process, and looks forward to continuing to work with stakeholders through the rulemaking process to maximize the value and learning from the proposed tests.

Medicare Part B covers prescription drugs that are administered in a physician’s office or hospital outpatient department, such as cancer medications, injectables like antibiotics, or eye care treatments. The proposed Medicare Part B Model would test new ways to support physicians and other clinicians as they choose the drug that is right for their patients. Continue reading

CMS Announces $32 Million to Help Get Eligible Children Enrolled in Health Coverage

Kid Mom PharmacistWashington, DC, November 17, 2015 ― The Centers for Medicare & Medicaid Services yesterday announced $32 million in available funds to support efforts to reach out to families with children eligible for Medicaid and the Children’s Health Insurance Program (CHIP) and help get them covered.

The funds will support activities aimed at alerting families to the availability of free or low-cost health coverage under Medicaid and CHIP, identifying children likely to be eligible, and assisting families with the application and renewal process. Medicaid and CHIP provide comprehensive coverage to the nation’s most vulnerable children. Continue reading

New Medicare Part D Opioid Drug Mapping Tool Available

Baltimore, MD, November 3, 2015 ― The Centers for Medicare & Medicaid Services (CMS) released an interactive online mapping tool (http://go.cms.gov/opioidheatmap) that shows geographic comparisons at the state, county, and ZIP code levels of de-identified Medicare Part D opioid prescription claims — prescriptions written and then submitted to be filled — within the United States.

This new mapping tool allows the user to see both the number and percentage of opioid claims at the local level and better understand how this critical issue impacts communities nationwide. Continue reading

Medicare and Medicaid Celebrate 50 Years; 55 Million Americans Covered by Medicare; New State Enrollment Numbers

President Lyndon B. Johnson Signs Medicare Bill July 30 1965Washington, DC, July 30, 2015 ― On July 30, 1965, President Lyndon B. Johnson—with former President Harry S. Truman at his side—signed the Social Security Amendments, which established Medicare and Medicaid, promising that they would “improve a wide range of health and medical services for Americans of all ages.”

As Medicare and Medicaid today celebrate their 50th anniversary protecting the health and well-being of millions of seniors, people with disabilities and low-income individuals, the Centers for Medicare & Medicaid Services (CMS) has released updated Medicare state-by-state enrollment numbers, showing that more than 55 million Americans are covered by Medicare.

In 1966, approximately 19.1 million Americans were covered by Medicare. In 2012, there were nearly 52 million beneficiaries covered by Medicare.  Today’s enrollment numbers represent a three million person increase during the last three years as the Baby Boom generation has started to retire. Continue reading

Medicare Prescription Drug Premiums Projected to Remain Stable in 2016

Washington, DC, July 30, 2015 ― On the eve of the 50th anniversary of the signing of Medicare and Medicaid into law, the Centers for Medicare & Medicaid Services (CMS) projected today that the average premium for a basic Medicare Part D prescription drug plan in 2016 will remain stable, at an estimated $32.50 per month.

“Seniors and people with disabilities are continuing to benefit from stable prescription drug premiums and a competitive and transparent marketplace for Medicare drug plans,” said acting CMS Administrator Andy Slavitt.

“While this is good news, we must ensure that Medicare Part D remains affordable for Medicare beneficiaries so that they can have access to the prescription drugs that they need,” Slavitt added. Continue reading